FDFT1 and glycogen storage disease VI: Puniya et al. recently predicted in a computational model based on multi-omic data Farnesyl-diphosphate farnesyltransferase 1 (FDFT1) as drug target candidate in T-cell mediated diseases such as RA and multiple sclerosis (20).